More than 2 million Americans suffer from Age-related Macular Degeneration (AMD), the leading cause of blindness among white Americans over 40, and the leading cause of irreversible vision loss throughout the world. Although there is no treatment for the more common form of the disease, Dry AMD, there are promising new treatments for Wet AMD, which is currently treated with injections of anti-VEGF drugs into the eye on a regular basis. New treatments that are creating hope with Wet AMD sufferers include gene therapy that provides a “one-and-done” treatment to help the eye produce its own anti-VEGF medicine, and a tiny refillable device smaller than a grain of rice that stores anti-VEGF medicine, and can be implanted into the wall of the eye. Learn more about new developments for treating both Wet and Dry AMD at http://bit.ly/2VfwBWQ, and be sure to share with friends or loved ones who suffer from AMD.
